Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?

SUMMARY: The volume of the hippocampus is reduced in patients with schizophrenia, and this deficit tends to become more pronounced with chronicity. Newer antipsychotics may protect against the progressive reductions in hippocampal volume while preliminary data offer hope that specific antipsychotics...

Descripción completa

Detalles Bibliográficos
Autor principal: Frangou, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Psychiatrists 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995174/
https://www.ncbi.nlm.nih.gov/pubmed/27703789
http://dx.doi.org/10.1192/bjpo.bp.116.002857
_version_ 1782449423614214144
author Frangou, Sophia
author_facet Frangou, Sophia
author_sort Frangou, Sophia
collection PubMed
description SUMMARY: The volume of the hippocampus is reduced in patients with schizophrenia, and this deficit tends to become more pronounced with chronicity. Newer antipsychotics may protect against the progressive reductions in hippocampal volume while preliminary data offer hope that specific antipsychotics may act to reverse it. DECLARATION OF INTEREST: None. COPYRIGHT AND USAGE: © The Royal College of Psychiatrists 2016. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence.
format Online
Article
Text
id pubmed-4995174
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Royal College of Psychiatrists
record_format MEDLINE/PubMed
spelling pubmed-49951742016-10-04 Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists? Frangou, Sophia BJPsych Open Editorial SUMMARY: The volume of the hippocampus is reduced in patients with schizophrenia, and this deficit tends to become more pronounced with chronicity. Newer antipsychotics may protect against the progressive reductions in hippocampal volume while preliminary data offer hope that specific antipsychotics may act to reverse it. DECLARATION OF INTEREST: None. COPYRIGHT AND USAGE: © The Royal College of Psychiatrists 2016. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence. The Royal College of Psychiatrists 2016-07-12 /pmc/articles/PMC4995174/ /pubmed/27703789 http://dx.doi.org/10.1192/bjpo.bp.116.002857 Text en © 2016 The Royal College of Psychiatrists http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Frangou, Sophia
Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?
title Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?
title_full Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?
title_fullStr Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?
title_full_unstemmed Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?
title_short Bulking up the hippocampus in schizophrenia: a role for 5-HT(1A) agonists?
title_sort bulking up the hippocampus in schizophrenia: a role for 5-ht(1a) agonists?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995174/
https://www.ncbi.nlm.nih.gov/pubmed/27703789
http://dx.doi.org/10.1192/bjpo.bp.116.002857
work_keys_str_mv AT frangousophia bulkingupthehippocampusinschizophreniaarolefor5ht1aagonists

Ejemplares similares